18 Spam-Free Article(s) Found
Symbol Name Last Close Mkt Cap DailyStocks'
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Tuesday’s Close
EC Ecopetrol S.A. $25.79 $53.02B Downtrend
Article Searches
Ecopetrol SA (EC) CEO Felipe Bayón on Q4 2018 Results - Earnings Call Transcript https://seekingalpha.com/article/4244902-ecopetrol-sa-ec-ceo-felipe-bayon-q4-2018-results-earnings-call-transcript?source=feed_sector_transcripts Feb 27, 2019 - Ecopetrol SA (NYSE:EC) Q4 2018 Earnings Conference Call February 27, 2019, 09:30 ET Company Participants Felipe Bayón - CEO Jorge Calvache - VP, Exploration Rafael Guzman - Technical Vice-President Al
Ecopetrol Allocates $500M of Capital Outlay for Fracking http://www.zacks.com/stock/news/358056/ecopetrol-allocates-%24500m-of-capital-outlay-for-fracking?cid=CS-ZC-FT-358056 Mar 07, 2019 - Ecopetrol (EC) is set to invest $500 million toward exploring unconventional deposits in the 2019-2021 time frame, beginning with shale pilot programs in Colombia???s shale-rich Magadalena Valley basin.
EC OK's Merck's Keytruda in first-line lung cancer https://seekingalpha.com/news/3442663-ec-oks-mercks-keytruda-first-line-lung-cancer?source=feed_news_all Mar 14, 2019 - As expected, the European Commision approves Merck's (NYSE:MRK) Keytruda (pembrolizumab), combined with carboplatin and Celgene's (NASDAQ:CELG) Abraxane (paclitaxel protein-bound), for the first-line
EC OK's expanded use for Roche's Hemlibra https://seekingalpha.com/news/3442658-ec-oks-expanded-use-roches-hemlibra?source=feed_news_all Mar 14, 2019 - The European Commission (EC) approves Roche's (OTCQX:RHHBY) Hemlibra (emicizumab) for routine prophylaxis of bleeding episodes in people with severe haemophilia A (congenital factor VIII defic
The Daily Biotech Pulse: Arsanis Completes X4 Merger, EC Nod For Roche, Axovant Offering http://feeds.benzinga.com/~r/benzinga/~3/luqnX1mkMuQ/the-daily-biotech-pulse-arsanis-completes-x4-merger-ec-nod-for-roche- Mar 14, 2019 -

Here's a roundup of top developments in the biotech space over the last 24 hours.

Scaling The Peaks

(Biotech stocks hitting 52-week highs on March 13)

read more

Roche Receives EC Approval for Label Expansion of Hemlibra http://www.zacks.com/stock/news/359564/roche-receives-ec-approval-for-label-expansion-of-hemlibra?cid=CS-ZC-FT-359564 Mar 14, 2019 - Roche (RHHBY) gets approval from European Commission for a label expansion of hemophilia drug, Hemlibra.
AstraZeneca's Forxiga Gets EC Approval for Type-I Diabetes http://www.zacks.com/stock/news/364120/astrazenecas-forxiga-gets-ec-approval-for-type-i-diabetes?cid=CS-ZC-FT-364120 Mar 25, 2019 - AstraZeneca's (AZN) diabetes drug gets approval in Europe for type-1 diabetes as an adjunct to insulin in patients with a BMI greater or equal to 27 kg/m2.
Ecopetrol's (EC) CEO Felipe Bayón on Q1 2019 Results - Earnings Call Transcript https://seekingalpha.com/article/4261162-ecopetrols-ec-ceo-felipe-bayon-q1-2019-results-earnings-call-transcript?source=feed_sector_transcripts May 07, 2019 - Ecopetrol S.A. (NYSE:EC) Q1 2019 Earnings Conference Call May 7, 2019 10:30 AM ET Company Participants María Catalina Escobar – Head-Capital Markets Felipe Bayón – Chief Executive Officer Alberto Cons
Ecopetrol S.A. (EC) Q1 2019 Earnings Call Transcript https://www.fool.com/earnings/call-transcripts/2019/05/08/ecopetrol-sa-ec-q1-2019-earnings-call-transcript.aspx?source=iedfolrf0000001 May 08, 2019 - EC earnings call for the period ending March 31, 2019.
Top Ranked Income Stocks to Buy for May 14th http://www.zacks.com/commentary/413935/top-ranked-income-stocks-to-buy-for-may-14th?cid=CS-ZC-FT-413935 May 14, 2019 - Top Ranked Income Stocks to Buy for May 14th

Pages: 12

Page 1